Lipoparticles for Synergistic Chemo-Photodynamic Therapy to Ovarian Carcinoma Cells: In vitro and in vivo Assessments

Sajid Ali,1 Muhammad Umair Amin,1,2 Imran Tariq,1,3 Muhammad Farhan Sohail,4,5 Muhammad Yasir Ali,1,6 Eduard Preis,1 Ghazala Ambreen,1 Shashank Reddy Pinnapireddy,1 Jarmila Jedelská,1 Jens Schäfer,1 Udo Bakowsky1 1Department of Pharmaceutics and Biopharmaceutics, University of Ma...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ali S, Amin MU, Tariq I, Sohail MF, Ali MY, Preis E, Ambreen G, Pinnapireddy SR, Jedelská J, Schäfer J, Bakowsky U
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
tem
Acceso en línea:https://doaj.org/article/9a48d1ef0da24530a73d99c9338f5feb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9a48d1ef0da24530a73d99c9338f5feb
record_format dspace
institution DOAJ
collection DOAJ
language EN
topic atomic force microscopy
facs
in vivo
in vitro cytotoxicity
lipid-polymer hybrid nanoparticles
photodynamic therapy
plga nanoparticles
tem
Medicine (General)
R5-920
spellingShingle atomic force microscopy
facs
in vivo
in vitro cytotoxicity
lipid-polymer hybrid nanoparticles
photodynamic therapy
plga nanoparticles
tem
Medicine (General)
R5-920
Ali S
Amin MU
Tariq I
Sohail MF
Ali MY
Preis E
Ambreen G
Pinnapireddy SR
Jedelská J
Schäfer J
Bakowsky U
Lipoparticles for Synergistic Chemo-Photodynamic Therapy to Ovarian Carcinoma Cells: In vitro and in vivo Assessments
description Sajid Ali,1 Muhammad Umair Amin,1,2 Imran Tariq,1,3 Muhammad Farhan Sohail,4,5 Muhammad Yasir Ali,1,6 Eduard Preis,1 Ghazala Ambreen,1 Shashank Reddy Pinnapireddy,1 Jarmila Jedelská,1 Jens Schäfer,1 Udo Bakowsky1 1Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Marburg, Germany; 2Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan; 3Punjab University College of Pharmacy, University of the Punjab, Allama Iqbal Campus, Lahore, Pakistan; 4Riphah Institute of Pharmaceutical Sciences (RIPS), Riphah International University, Lahore, Pakistan; 5Department of Pharmacy, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark; 6Faculty of Pharmaceutical Sciences, GC University Faisalabad, Faisalabad, PakistanCorrespondence: Udo BakowskyDepartment of Pharmaceutics and Biopharmaceutics, University of Marburg, Robert Koch Str. 4, Marburg, 35037, GermanyTel + 49 6421 28 25884Fax + 49 6421 28 27016Email ubakowsky@aol.comPurpose: Lipoparticles are the core-shell type lipid-polymer hybrid systems comprising polymeric nanoparticle core enveloped by single or multiple pegylated lipid layers (shell), thereby melding the biomimetic properties of long-circulating vesicles as well as the mechanical advantages of the nanoparticles. The present study was aimed at the development of such an integrated system, combining the photodynamic and chemotherapeutic approaches for the treatment of multidrug-resistant cancers.Methods: For this rationale, two different sized Pirarubicin (THP) loaded poly lactic-co-glycolic acid (PLGA) nanoparticles were prepared by emulsion solvent evaporation technique, whereas liposomes containing Temoporfin (mTHPC) were prepared by lipid film hydration method. Physicochemical and morphological characterizations were done using dynamic light scattering, laser doppler anemometry, atomic force microscopy, and transmission electron microscopy. The quantitative assessment of cell damage was determined using MTT and reactive oxygen species (ROS) assay. The biocompatibility of the nanoformulations was evaluated with serum stability testing, haemocompatibility as well as acute in vivo toxicity using female albino (BALB/c) mice.Results and Conclusion: The mean hydrodynamic diameter of the formulations was found between 108.80 ± 2.10 to  405.70 ± 10.00 nm with the zeta (ζ) potential ranging from − 12.70 ± 1.20 to 5.90 ± 1.10 mV. Based on the physicochemical evaluations, the selected THP nanoparticles were coated with mTHPC liposomes to produce lipid-coated nanoparticles (LCNPs). A significant (p< 0.001) cytotoxicity synergism was evident in LCNPs when irradiated at 652 nm, using an LED device. No incidence of genotoxicity was observed as seen with the comet assay. The LCNPs decreased the generalized in vivo toxicity as compared to the free drugs and was evident from the serum biochemical profile, visceral body index, liver function tests as well as renal function tests. The histopathological examinations of the vital organs revealed no significant evidence of toxicity suggesting the safety and efficacy of our lipid-polymer hybrid system.Keywords: atomic force microscopy, FACS, in vivo, in vitro cytotoxicity, lipid-polymer hybrid nanoparticles, photodynamic therapy, PLGA nanoparticles, TEM
format article
author Ali S
Amin MU
Tariq I
Sohail MF
Ali MY
Preis E
Ambreen G
Pinnapireddy SR
Jedelská J
Schäfer J
Bakowsky U
author_facet Ali S
Amin MU
Tariq I
Sohail MF
Ali MY
Preis E
Ambreen G
Pinnapireddy SR
Jedelská J
Schäfer J
Bakowsky U
author_sort Ali S
title Lipoparticles for Synergistic Chemo-Photodynamic Therapy to Ovarian Carcinoma Cells: In vitro and in vivo Assessments
title_short Lipoparticles for Synergistic Chemo-Photodynamic Therapy to Ovarian Carcinoma Cells: In vitro and in vivo Assessments
title_full Lipoparticles for Synergistic Chemo-Photodynamic Therapy to Ovarian Carcinoma Cells: In vitro and in vivo Assessments
title_fullStr Lipoparticles for Synergistic Chemo-Photodynamic Therapy to Ovarian Carcinoma Cells: In vitro and in vivo Assessments
title_full_unstemmed Lipoparticles for Synergistic Chemo-Photodynamic Therapy to Ovarian Carcinoma Cells: In vitro and in vivo Assessments
title_sort lipoparticles for synergistic chemo-photodynamic therapy to ovarian carcinoma cells: in vitro and in vivo assessments
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/9a48d1ef0da24530a73d99c9338f5feb
work_keys_str_mv AT alis lipoparticlesforsynergisticchemophotodynamictherapytoovariancarcinomacellsinvitroandinvivoassessments
AT aminmu lipoparticlesforsynergisticchemophotodynamictherapytoovariancarcinomacellsinvitroandinvivoassessments
AT tariqi lipoparticlesforsynergisticchemophotodynamictherapytoovariancarcinomacellsinvitroandinvivoassessments
AT sohailmf lipoparticlesforsynergisticchemophotodynamictherapytoovariancarcinomacellsinvitroandinvivoassessments
AT alimy lipoparticlesforsynergisticchemophotodynamictherapytoovariancarcinomacellsinvitroandinvivoassessments
AT preise lipoparticlesforsynergisticchemophotodynamictherapytoovariancarcinomacellsinvitroandinvivoassessments
AT ambreeng lipoparticlesforsynergisticchemophotodynamictherapytoovariancarcinomacellsinvitroandinvivoassessments
AT pinnapireddysr lipoparticlesforsynergisticchemophotodynamictherapytoovariancarcinomacellsinvitroandinvivoassessments
AT jedelskaj lipoparticlesforsynergisticchemophotodynamictherapytoovariancarcinomacellsinvitroandinvivoassessments
AT schaferj lipoparticlesforsynergisticchemophotodynamictherapytoovariancarcinomacellsinvitroandinvivoassessments
AT bakowskyu lipoparticlesforsynergisticchemophotodynamictherapytoovariancarcinomacellsinvitroandinvivoassessments
_version_ 1718390670270398464
spelling oai:doaj.org-article:9a48d1ef0da24530a73d99c9338f5feb2021-12-02T14:39:24ZLipoparticles for Synergistic Chemo-Photodynamic Therapy to Ovarian Carcinoma Cells: In vitro and in vivo Assessments1178-2013https://doaj.org/article/9a48d1ef0da24530a73d99c9338f5feb2021-02-01T00:00:00Zhttps://www.dovepress.com/lipoparticles-for-synergistic-chemo-photodynamic-therapy-to-ovarian-ca-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Sajid Ali,1 Muhammad Umair Amin,1,2 Imran Tariq,1,3 Muhammad Farhan Sohail,4,5 Muhammad Yasir Ali,1,6 Eduard Preis,1 Ghazala Ambreen,1 Shashank Reddy Pinnapireddy,1 Jarmila Jedelská,1 Jens Schäfer,1 Udo Bakowsky1 1Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Marburg, Germany; 2Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan; 3Punjab University College of Pharmacy, University of the Punjab, Allama Iqbal Campus, Lahore, Pakistan; 4Riphah Institute of Pharmaceutical Sciences (RIPS), Riphah International University, Lahore, Pakistan; 5Department of Pharmacy, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark; 6Faculty of Pharmaceutical Sciences, GC University Faisalabad, Faisalabad, PakistanCorrespondence: Udo BakowskyDepartment of Pharmaceutics and Biopharmaceutics, University of Marburg, Robert Koch Str. 4, Marburg, 35037, GermanyTel + 49 6421 28 25884Fax + 49 6421 28 27016Email ubakowsky@aol.comPurpose: Lipoparticles are the core-shell type lipid-polymer hybrid systems comprising polymeric nanoparticle core enveloped by single or multiple pegylated lipid layers (shell), thereby melding the biomimetic properties of long-circulating vesicles as well as the mechanical advantages of the nanoparticles. The present study was aimed at the development of such an integrated system, combining the photodynamic and chemotherapeutic approaches for the treatment of multidrug-resistant cancers.Methods: For this rationale, two different sized Pirarubicin (THP) loaded poly lactic-co-glycolic acid (PLGA) nanoparticles were prepared by emulsion solvent evaporation technique, whereas liposomes containing Temoporfin (mTHPC) were prepared by lipid film hydration method. Physicochemical and morphological characterizations were done using dynamic light scattering, laser doppler anemometry, atomic force microscopy, and transmission electron microscopy. The quantitative assessment of cell damage was determined using MTT and reactive oxygen species (ROS) assay. The biocompatibility of the nanoformulations was evaluated with serum stability testing, haemocompatibility as well as acute in vivo toxicity using female albino (BALB/c) mice.Results and Conclusion: The mean hydrodynamic diameter of the formulations was found between 108.80 ± 2.10 to  405.70 ± 10.00 nm with the zeta (ζ) potential ranging from − 12.70 ± 1.20 to 5.90 ± 1.10 mV. Based on the physicochemical evaluations, the selected THP nanoparticles were coated with mTHPC liposomes to produce lipid-coated nanoparticles (LCNPs). A significant (p< 0.001) cytotoxicity synergism was evident in LCNPs when irradiated at 652 nm, using an LED device. No incidence of genotoxicity was observed as seen with the comet assay. The LCNPs decreased the generalized in vivo toxicity as compared to the free drugs and was evident from the serum biochemical profile, visceral body index, liver function tests as well as renal function tests. The histopathological examinations of the vital organs revealed no significant evidence of toxicity suggesting the safety and efficacy of our lipid-polymer hybrid system.Keywords: atomic force microscopy, FACS, in vivo, in vitro cytotoxicity, lipid-polymer hybrid nanoparticles, photodynamic therapy, PLGA nanoparticles, TEMAli SAmin MUTariq ISohail MFAli MYPreis EAmbreen GPinnapireddy SRJedelská JSchäfer JBakowsky UDove Medical Pressarticleatomic force microscopyfacsin vivoin vitro cytotoxicitylipid-polymer hybrid nanoparticlesphotodynamic therapyplga nanoparticlestemMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 951-976 (2021)